VIROMED MEDICAL NA O.N. Asset Resilience Ratio
VIROMED MEDICAL NA O.N. asset resilience ratio. VIROMED MEDICAL NA O.N. (VME) has an Asset Resilience Ratio of 0.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read VME total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of VIROMED MEDICAL NA O.N. (2024–2025)
Asset resilience ratio of VIROMED MEDICAL NA O.N. from 2024 to 2025. This chart shows how VIROMED MEDICAL NA O.N.'s Asset Resilience Ratio has changed over time. See VME equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down VIROMED MEDICAL NA O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VIROMED MEDICAL NA O.N. asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €4.51K | 0.03% |
| Total Liquid Assets | €4.51K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: VIROMED MEDICAL NA O.N. maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
VIROMED MEDICAL NA O.N. Industry Peers by Asset Resilience Ratio
Compare VIROMED MEDICAL NA O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Control Bionics Ltd
AU:CBL |
Medical Devices | 0.95% |
VIROMED MEDICAL NA O.N. Asset Resilience Ratio by Year (2024–2025)
VIROMED MEDICAL NA O.N. asset resilience ratio by year from 2024 to 2025. The table below shows the annual Asset Resilience Ratio data for VIROMED MEDICAL NA O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.03% | €4.51K ≈ $5.28K |
€13.91 Million ≈ $16.27 Million |
+0.00pp |
| 2024-12-31 | 0.03% | €3.78K ≈ $4.42K |
€13.40 Million ≈ $15.66 Million |
-- |
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.